In this episode of ATTD 2025 Conference Catch-Up, we dive into Early Detection: Innovative Technologies for Type 1 Diabetes Diagnosis, featuring groundbreaking discussions on population-level screening, antibody detection, and strategies to implement early detection of Type 1 diabetes globally. Join us as we summarize key takeaways from these thought-provoking presentations: General Population Screening – Successes and Pitfalls – Dr. Anastasia Albanese-O’Neill Update on ADIR (Antibody Detection Israeli Research) Project – Prof. Moshe Phillip & Dr. Tal Oron Screening of Type 1 Diabetes and Celiac Disease of the General Pediatric Population in Italy: Progress and Preliminary Results – Prof. Emanuele Bosi EDENT1FI: Toward General Population Screening in Europe – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, diabetes researchers, public health professionals, and anyone involved in diabetes prevention, looking to stay updated on the latest advancements in early diagnosis and screening strategies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related